UNASSIGNED: We performed a secondary analysis of deidentified data for all payers from 53 centers registered in the HBOTR from 2013 to 2022. We estimated the mean annual per-patient costs of HBO2 based on Medicare (outpatient facility + physician) reimbursement fees adjusted to 2022 inflation using the Medicare Economic Index. Costs were calculated for the annual average number of treatments patients received each year and for a standard 40-treatment series. We estimated the 2022 costs of standard treatment protocols for HBO2 indications treated in the outpatient setting.
UNASSIGNED: Generally, all costs decreased from 2013 to 2022. The facility cost per patient per 40 HBO2 treatments decreased by 10.7% from $21,568.58 in 2013 to $19,488.00 in 2022. The physician cost per patient per 40 treatments substantially decreased by -37.8%, from $5,993.16 to $4,346.40. The total cost per patient per 40 treatments decreased by 15.6% from $27,561.74 to $23,834.40. In 2022, a single HBO2 session cost $595.86. For different indications, estimated costs ranged from $2,383.4-$8,342.04 for crush injuries to $17,875.80-$35,751.60 for diabetic foot ulcers and delayed radiation injuries.
UNASSIGNED: This real-world analysis of registry data demonstrates that the actual cost of HBO2 is not nearly as costly as the literature has insinuated, and the per-patient cost to Medicare is decreasing, largely due to decreased physician costs.
■我们对2013年至2022年在HBOTR注册的53个中心的所有付款人的未识别数据进行了二次分析。我们根据Medicare(门诊设施+医生)报销费用,使用Medicare经济指数调整到2022年通货膨胀,估计了HBO2的平均每年每位患者费用。根据每年接受治疗的患者的年平均数量和标准40治疗系列计算费用。我们估计了2022年门诊治疗HBO2适应症的标准治疗方案的成本。
■一般来说,从2013年到2022年,所有成本都有所下降。每40例HBO2治疗的每位患者的设施费用从2013年的21,568.58美元下降到2022年的19,488.00美元,下降了10.7%。每位患者每40次治疗的医师费用大幅下降-37.8%,从5,993.16美元到4,346.40美元。每位患者每40次治疗的总费用从27,561.74美元下降到23,834.40美元,下降了15.6%。2022年,一个HBO2会议的费用为595.86美元。对于不同的适应症,估计费用从挤压伤的$2,383.4-$8,342.04到糖尿病足溃疡和延迟放射损伤的$17,875.80-$35,751.60不等。
■对注册数据的实际分析表明,HBO2的实际成本并不像文献所暗示的那样昂贵,医疗保险的每位患者费用正在下降,主要是由于医生费用下降。